Earth Science Tech, Inc. (OTC: ETST) announced financial results for the fiscal year ended March 31, 2026, showcasing revenue growth and improved profitability. The company reported revenue of $35.7 million, an 8% increase from the prior year, and gross profit of $25.5 million, up 5%. Net income rose 11% to $3.6 million, reflecting the company's focus on operational efficiency and strategic capital allocation. Total assets increased 27% year over year to $9.0 million, underscoring the expansion of its integrated healthcare platform, which encompasses telemedicine, pharmacy, and fulfillment services.
Management highlighted the company's capital allocation strategy, noting that Earth Science Tech repurchased and retired more than 4 million shares during fiscal 2026. Through fiscal 2026 and subsequent periods, the company has repurchased over 7.1 million shares. The company generated positive operating cash flow and strengthened its balance sheet without incurring additional debt. As it enters fiscal 2027, the company remains focused on growth initiatives, product expansion, and continued share repurchases.
Earth Science Tech operates as a diversified holding company in the health and wellness sector, building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. The core value proposition lies in the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries.
For more details, the full press release is available at https://ibn.fm/NpjTw. The latest news and updates relating to ETST can be found in the company's newsroom at https://ibn.fm/ETST.
